[
  {
    "ts": null,
    "headline": "Campbell’s Appoints Kelly L. Palumbo Senior Vice President, Controller and Chief Accounting Officer",
    "summary": "CAMDEN, N.J., September 04, 2025--The Campbell’s Company (NASDAQ:CPB) (Campbell’s) today announced the appointment of Kelly L. Palumbo as Senior Vice President, Controller and Chief Accounting Officer, effective Sept. 22, 2025. She succeeds Stan Polomski who is being appointed to the newly created role of Senior Vice President, Business Process Optimization in the company’s Enterprise Transformation Office.",
    "url": "https://finnhub.io/api/news?id=adfd14b84643db14bcc7a55e0e4eb640dc4806bdebc194d14af3ce8d423ad6fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757021400,
      "headline": "Campbell’s Appoints Kelly L. Palumbo Senior Vice President, Controller and Chief Accounting Officer",
      "id": 136641799,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "CAMDEN, N.J., September 04, 2025--The Campbell’s Company (NASDAQ:CPB) (Campbell’s) today announced the appointment of Kelly L. Palumbo as Senior Vice President, Controller and Chief Accounting Officer, effective Sept. 22, 2025. She succeeds Stan Polomski who is being appointed to the newly created role of Senior Vice President, Business Process Optimization in the company’s Enterprise Transformation Office.",
      "url": "https://finnhub.io/api/news?id=adfd14b84643db14bcc7a55e0e4eb640dc4806bdebc194d14af3ce8d423ad6fa"
    }
  },
  {
    "ts": null,
    "headline": "Is the Recent Pipeline Progress on its NSCLC Drug Enough for BDTX?",
    "summary": "Black Diamond focuses on silevertinib for NSCLC and GBM, with key trial readouts due in late 2025 and FDA feedback expected in 2026.",
    "url": "https://finnhub.io/api/news?id=bf0576469f70e206ff89db5992d4a2664ee50ae057e35c14befd27543354d406",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757000760,
      "headline": "Is the Recent Pipeline Progress on its NSCLC Drug Enough for BDTX?",
      "id": 136641800,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Black Diamond focuses on silevertinib for NSCLC and GBM, with key trial readouts due in late 2025 and FDA feedback expected in 2026.",
      "url": "https://finnhub.io/api/news?id=bf0576469f70e206ff89db5992d4a2664ee50ae057e35c14befd27543354d406"
    }
  },
  {
    "ts": null,
    "headline": "Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?",
    "summary": "ABBV's expanding neuroscience portfolio, led by Botox, Vraylar and new launches like Vyalev, continues to fuel top-line growth.",
    "url": "https://finnhub.io/api/news?id=af41cf519e3e52d121a28bf7418c92a9d4791bec6c84aed8ec79b7ab8e2ce6d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756995420,
      "headline": "Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?",
      "id": 136641801,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "ABBV's expanding neuroscience portfolio, led by Botox, Vraylar and new launches like Vyalev, continues to fuel top-line growth.",
      "url": "https://finnhub.io/api/news?id=af41cf519e3e52d121a28bf7418c92a9d4791bec6c84aed8ec79b7ab8e2ce6d6"
    }
  },
  {
    "ts": null,
    "headline": "Tissue Engineering and Regeneration Technology Global Market Report 2025 & 2026-2030 | Focus on ESG, Technological Advancements, and Competitive Landscape",
    "summary": "The report on the global tissue engineering and regeneration market analyses trends, covering 2024-2030. Segments include product type, material, and application across major regions. The study highlights key trends, challenges, ESG developments, and emerging technologies. It features market size, revenue forecasts, competitive landscape, and company profiles like Organogenesis and Johnson & Johnson. Ideal for stakeholders seeking insights into market dynamics and future growth prospects. Global",
    "url": "https://finnhub.io/api/news?id=2608fc58aebc8c5c0322e4a5585c10c517e63b5605d3f1aa3222c2ad060e285e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756984440,
      "headline": "Tissue Engineering and Regeneration Technology Global Market Report 2025 & 2026-2030 | Focus on ESG, Technological Advancements, and Competitive Landscape",
      "id": 136641802,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The report on the global tissue engineering and regeneration market analyses trends, covering 2024-2030. Segments include product type, material, and application across major regions. The study highlights key trends, challenges, ESG developments, and emerging technologies. It features market size, revenue forecasts, competitive landscape, and company profiles like Organogenesis and Johnson & Johnson. Ideal for stakeholders seeking insights into market dynamics and future growth prospects. Global",
      "url": "https://finnhub.io/api/news?id=2608fc58aebc8c5c0322e4a5585c10c517e63b5605d3f1aa3222c2ad060e285e"
    }
  },
  {
    "ts": null,
    "headline": "Kardium receives FDA OK for pulsed field ablation system",
    "summary": "The company raised $250 million in July to expand its manufacturing capabilities and establish multiple teams to support the launch.",
    "url": "https://finnhub.io/api/news?id=7d74e98e8c7ce52c28eddbe261b371c94413b59c98dc86bb171a68a64e7d34be",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756983600,
      "headline": "Kardium receives FDA OK for pulsed field ablation system",
      "id": 136641803,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The company raised $250 million in July to expand its manufacturing capabilities and establish multiple teams to support the launch.",
      "url": "https://finnhub.io/api/news?id=7d74e98e8c7ce52c28eddbe261b371c94413b59c98dc86bb171a68a64e7d34be"
    }
  },
  {
    "ts": null,
    "headline": "Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?",
    "summary": "There is more to like than the dividend with these companies.",
    "url": "https://finnhub.io/api/news?id=2ec085e7fd47269aacd4a66e5057f6c9f5ee57297e2bf861174fbcf85abcc7d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756976940,
      "headline": "Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?",
      "id": 136641804,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "There is more to like than the dividend with these companies.",
      "url": "https://finnhub.io/api/news?id=2ec085e7fd47269aacd4a66e5057f6c9f5ee57297e2bf861174fbcf85abcc7d7"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Launches First Daily Disposable Toric Contact Lens Designed to Deliver on the Specific Needs of Low and High Astigmatic Patients in United Kingdom and Ireland (UKI)",
    "summary": "World’s #1 Selling Contact Lens Brand ACUVUE®1 Brings Pioneering Innovation For Astigmatic Patients, Providing Visual Clarity And Comfort+2 The First^^ Toric Lens to have an Optimised Design according to Cylinder Power Wokingham, UK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Today, Johnson & Johnson, a global leader in eye health, announced the launch of a new product for astigmatic patients in UKI – ACUVUE® OASYS MAX 1-Day Contact Lenses for Astigmatism – the first contact lens to optimise toric desig",
    "url": "https://finnhub.io/api/news?id=7b252c05da53991de801d6aef6dd62ccba02757f5e8d0b553187955886856d29",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756972800,
      "headline": "Johnson & Johnson Launches First Daily Disposable Toric Contact Lens Designed to Deliver on the Specific Needs of Low and High Astigmatic Patients in United Kingdom and Ireland (UKI)",
      "id": 136641805,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "World’s #1 Selling Contact Lens Brand ACUVUE®1 Brings Pioneering Innovation For Astigmatic Patients, Providing Visual Clarity And Comfort+2 The First^^ Toric Lens to have an Optimised Design according to Cylinder Power Wokingham, UK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Today, Johnson & Johnson, a global leader in eye health, announced the launch of a new product for astigmatic patients in UKI – ACUVUE® OASYS MAX 1-Day Contact Lenses for Astigmatism – the first contact lens to optimise toric desig",
      "url": "https://finnhub.io/api/news?id=7b252c05da53991de801d6aef6dd62ccba02757f5e8d0b553187955886856d29"
    }
  }
]